However, inhibition of p38 only reverts the immunotolerance of CD25− iTreg in the absence of CD25+Treg, suggesting that in order to prevent tumor growth and block the immunotolerance of CD25−iTreg, it is necessary to deplete CD25+Treg, in addition to inhibit p38MAPK [108]. Here, MAPK14 is linked to neoplasm.